ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral center

Background: Activating mutations in the ESR1 gene are a known mechanism of secondary resistance to endocrine therapy in metastatic estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2−) breast cancers. Liquid biopsy has become a non-invasive tool for molecularly c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Thais Maloberti, Laura Poppi, Giulia Ciccimara, Sara Coluccelli, Floriana Jessica Di Paola, Giulia Calafato, Viviana Sanza, Elisa Gruppioni, Annalisa Altimari, Sara Quercia, Alessandra Bernardi, Claudio Zamagni, Roberta Minari, Antonio De Leo, Giovanni Tallini, Dario de Biase
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-12-01
coleção:	The Journal of Liquid Biopsy
Assuntos:	Liquid biopsy ESR1 Breast cancer NGS ctDNA
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2950195425000475
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!